发明名称 N-ETHYL-4-HYDROXYL-1-METHYL-5-(METHYL(2,3,4,5,6-PENTAHYDROXYHEXYL) AMINO)-2-OXO-N-PHENYL-1,2-DIHYDROQUINOLINE-3-CARBOXAMIDE
摘要 The subject invention provides pharmaceutical compositions Containing laquinimod or a pharmaceutically acceptable salt thereof, an isolated compound of N-ethyl-4-hydroxyl-1 -methyl-5- (methyl (2, 3,4,5, 6-pentahydroxyhexyl ) amino) -2-oxo-N-phenyl-1, 2- dihydroquinoline- 3 -carboxamide or a salt thereof, compositions containing N-ethyl-4-hydroxyl-1-methyl-5- (methyl (2,3,4,5,6- pentahydroxyhexyl ) amino) -2-oxo-N-phenyl-1, 2-dihydroquinoline-3- carboxamide and methods of preparing the same.
申请公布号 WO2013169746(A2) 申请公布日期 2013.11.14
申请号 WO2013US39911 申请日期 2013.05.07
申请人 TEVA PHARMACEUTICAL INDUSTRIES LTD.;TEVA PHARMACEUTICALS USA, INC.;LAXER, AVITAL;ULANENKO, KONSTANTIN 发明人 LAXER, AVITAL;ULANENKO, KONSTANTIN
分类号 C07D215/56;A61K31/4704 主分类号 C07D215/56
代理机构 代理人
主权项
地址